medigraphic.com
ISSN 1405-8871 (Print)

2015, Number 1

<< Back Next >>

Aten Fam 2015; 22 (1)

Use of Psychoactive Drugs in a Group of Seniors from Rosario, Argentina

Agostini-Zampieron M, Aybar-Maino J, Heit-Barbini F, Arca-Fabre A, Mónaco-Ditieri MC

Language: Spanish
References: 18
Page: 10-13
PDF size: 224.52 Kb.


ABSTRACT

Objective: classify the type of psychoactive drugs used in elderly in a Clinical Research and Assistance Center. Methods: descriptive and cross-sectional study, carried out from January 2, 2011 to March 1, 2014; outpatients over 60 years old who attended the Assistance Center and Integral Research Clinic (caici), in Rosario, Argentina were included; and those who signed the respective informed consent. Data were analyzed using descriptive statistical techniques. Results: from a total of 667 patients, the sample only included 235. The highest age group of consumption was from 60 to 70 years (55%). Benzodiazepines were consumed in 67%, 3% antipsychotics and antidepressants 30%. Specialists in medical clinic prescribed 70% of benzodiazepines and antidepressants 20%. All antipsychotic drugs were prescribed by psychiatrists; 35 had a potential risk of interaction; the combinations were benzodiazepines and antidepressants. There was no risk of serotonin syndrome in the indication of citalopram and desvenlafaxine; no alterations were observed by the combination of benzodiazepines from the same group and the same mechanism of action. Conclusions: it was observed in this work an increase in the consumption of psychotropic drugs in patients older than 60 years, mainly in those who do not continue with an active life; regarding the gender there is a higher percentage in females. The majority of the patients received indication of benzodiazepines by their clinical physician.


REFERENCES

  1. Del Pozo Iribarra JA, Ruiz MA, Pardo A, San Martín R. Efectos de la duración del desempleo entre los desempleados. Psicothema. 2002;14:440-3.

  2. Zazone P, et al. A criterion-based review of preventive health care in the elderly. Part Z.A. Geriatric health maintenance program. J Fam Pract. 1992;34:320-47.

  3. Beers MH, Ouslander JG. Risk factors in geriatric drug prescribing. A practical guide to avoiding problems. 2005;37:105-12.

  4. Usall i Rodié, J. Psicofarmacología sensible al sexo: influencia del sexo en el tratamiento farmacológico de los trastornos psiquiátricos. Actas Españolas de Psiquiatría. 2004;32(5):307-13.

  5. Markez I, Póo M, Romo N, Meneses C, Gil E, Vega A. Mujeres y psicofármacos: la investigación en atención primaria. Revista de la Asociación Española de Neuropsiquiatría. 2004;91:37-61.

  6. Vilches MF. Utilización de psicofármacos por médicos no psiquiatras. Experiencia Médica. 2011;29(2):42-8.

  7. Yates KT, Catril MP. Tendencias en la utilización de benzodiacepinas en farmacia privada. Neuro- Psiquiat. 2009;47(1):9-15.

  8. Piazza M, Fiestas F. Prevalencia anual de trastornos y uso de servicios de salud mental en el Perú: resultados del estudio mundial de salud mental, 2005. Med Exp Salud Pública. 2014;31(1):30-8.

  9. Lanfranchi Moreno R, Rivera Meza B, Flores Valdés C, Secín Diep R. Prescripción de psicofármacos en el Hospital General Ángeles del Pedregal. Med Int Mex. 2006;22:501-7.

  10. Borges G, Medina-Mora ME, López- Moreno S. El papel de la epidemiología en la investigación de los trastornos mentales. Salud Pública Méx. 2004;46(5):451-63.

  11. Alvarenga JM, Loyola Filho AI, Firmo JO, Lima- -Costa MF, Uchoa E. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (bhas). Revista Brasileira de Psiquiatria. 2008;30(1): 7-11.

  12. Gleason PP, Schulz R, Smith NL, Newsom JT, Kroboth PD, Kroboz FJ, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13(4):243-50.

  13. Huf G, Lopes CS, Rozenfeld S. O uso prolongado de benzodiazepínicos em mulheres de um centro de convivência para idosos. Cad Saude Publica. 2000;16(2):351-62.

  14. Cheng JS, Huang WF, Lin KM, Shih YT. Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan. International journal of geriatric psychiatry. 2008;23(6):618-24.

  15. Cassano GB, Puca F, Scapicchio PL, Trabucchi M. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. The Journal of clinical Psychiatry. 2002;63(5):396-02.

  16. Udabe RU. The History of Psychotropic Drugs in Argentina. Reflections on Twentieth-Century. Psychopharmacology [Internet]. Disponible en: http://cinp.org/fileadmin/documents/history/ books/VOL4_opt.pdf#page=108.

  17. Sicras Mainar A, Peláez de Loño J. Mejora de la adecuación de uso de medicamentos y efectos en centros geriátricos mediante un programa de intervención. Farmacia Hospitalaria. 2005;29(5):303-11.

  18. Martínez Querol C, Pérez Martínez VT, Carballo Pérez M, Larrondo Viera JJ. Polifarmacia en los adultos mayores. Rev Cubana Med Gen Integr [Internet]. 2005[citado 2014 Nov 05];21(1-2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S0864-21252005000100012&lng=es.




2020     |     www.medigraphic.com